These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 3069436)
21. Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin. Kosoglou T; Statkevich P; Meyer I; Cutler DL; Musiol B; Yang B; Zhu Y; Maxwell SE; Veltri EP Curr Med Res Opin; 2004 Jun; 20(6):955-65. PubMed ID: 15200755 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic use of lovastatin in the treatment of hypercholesterolemia. Illingworth DR Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598 [TBL] [Abstract][Full Text] [Related]
23. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins. Richter WO; Jacob BG; Schwandt P Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291 [TBL] [Abstract][Full Text] [Related]
24. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731 [TBL] [Abstract][Full Text] [Related]
25. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis. Alberts AW Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667 [TBL] [Abstract][Full Text] [Related]
26. Combination therapy with low-dose lovastatin and niacin is as effective as higher-dose lovastatin. Gardner SF; Schneider EF; Granberry MC; Carter IR Pharmacotherapy; 1996; 16(3):419-23. PubMed ID: 8726600 [TBL] [Abstract][Full Text] [Related]
28. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study]. Forti N; Ramires JA Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203 [TBL] [Abstract][Full Text] [Related]
30. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination. Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043 [TBL] [Abstract][Full Text] [Related]
31. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs. van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883 [TBL] [Abstract][Full Text] [Related]
33. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits. Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875 [TBL] [Abstract][Full Text] [Related]
34. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]
35. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol. Hung YJ; Pei D; Wu DA; Kuo SW; Fuh MM; Jeng C J Formos Med Assoc; 1999 Feb; 98(2):104-10. PubMed ID: 10083765 [TBL] [Abstract][Full Text] [Related]
36. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
37. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia]. Idzior-Waluś B Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351 [TBL] [Abstract][Full Text] [Related]
38. Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs. Brown WV Cardiology; 1989; 76 Suppl 1():45-51; discussion 52-4. PubMed ID: 2653623 [TBL] [Abstract][Full Text] [Related]